Houtaï Choumane
Vorstandsvorsitzender bei KiOmed Pharma SA
Profil
Houtaï Choumane is currently the Chief Executive Officer and Director at KiOmed Pharma SA since 2014.
Prior to this, he was the Chairman and Chief Executive Officer at Genewave SAS from 2002 to 2009 and the Chief Executive Officer at Artialis SA. He holds a doctorate from the University of Orsay and an MBA from École des Hautes Études Commerciales de Paris.
Aktive Positionen von Houtaï Choumane
| Unternehmen | Position | Beginn |
|---|---|---|
KiOmed Pharma SA
 KiOmed Pharma SA Pharmaceuticals: MajorHealth Technology KiOmed Pharma SA develops pharmaceutical products. It offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. The company was founded by Francois Blondel and Yves Henrotin in 2015 and is headquartered in Herstal, Belgium. | Vorstandsvorsitzender | 01.03.2014 |
Ehemalige bekannte Positionen von Houtaï Choumane
| Unternehmen | Position | Ende |
|---|---|---|
Artialis SA
 Artialis SA Medical/Nursing ServicesHealth Services Artialis SA develops and commercializes immunoassays for the diagnostic and the prognostic disorders. Its products include Urine F3F ELISA, Urine COLL2-2NO2 ELISA, Urine COLL2-1NO2 ELISA and Urine COLL2-1 ELISA. The firm engages in development, analysis and marketing diagnostic kits including in the field of diseases of the musculoskeletal system of humans and animals. The company was founded in 2010 by Yves Henrotin and is headquartered in Liege, Belgium. | Vorstandsvorsitzender | - |
Genewave SAS
 Genewave SAS Medical SpecialtiesHealth Technology Genewave SAS developed, manufactured and marketed microarray instrumentation for the molecular diagnostic and life sciences markets. The company was founded by Claude Weisbuch, Henri Benisty and Francois Vallet in December 2001 and was headquartered in Evry, France. | Vorstandsvorsitzender | - |
Ausbildung von Houtaï Choumane
| University of Orsay | Doctorate Degree |
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Genewave SAS
Genewave SAS Medical SpecialtiesHealth Technology Genewave SAS developed, manufactured and marketed microarray instrumentation for the molecular diagnostic and life sciences markets. The company was founded by Claude Weisbuch, Henri Benisty and Francois Vallet in December 2001 and was headquartered in Evry, France. | Health Technology |
Artialis SA
Artialis SA Medical/Nursing ServicesHealth Services Artialis SA develops and commercializes immunoassays for the diagnostic and the prognostic disorders. Its products include Urine F3F ELISA, Urine COLL2-2NO2 ELISA, Urine COLL2-1NO2 ELISA and Urine COLL2-1 ELISA. The firm engages in development, analysis and marketing diagnostic kits including in the field of diseases of the musculoskeletal system of humans and animals. The company was founded in 2010 by Yves Henrotin and is headquartered in Liege, Belgium. | Health Services |
KiOmed Pharma SA
KiOmed Pharma SA Pharmaceuticals: MajorHealth Technology KiOmed Pharma SA develops pharmaceutical products. It offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. The company was founded by Francois Blondel and Yves Henrotin in 2015 and is headquartered in Herstal, Belgium. | Health Technology |
